AlphaYouCL
Insider selling
Camille L Bedrosian sold $325K of Amylyx Pharmaceuticals, Inc. (AMLX) stock
Camille L Bedrosian, Chief Medical Officer of Amylyx Pharmaceuticals, Inc. (AMLX), sold 10,028 shares of AMLX stock worth $325K, per an SEC Form 4 filed Sep 14, 2026.
It was an open-market sale.
The trade happened on Sep 10, 2026, 4 days before it was made public.
AMLX has moved +0.9% since the trade date, from $32.09 to $32.39 (Sep 21, 2026 close).
- Traded
- Sep 10, 2026
- Disclosed
- Sep 14, 2026
- Filing delay
- 4 days
- Price since
- +0.9%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
More AMLX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.